Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
If GLP-1 is to work effectively, food brands with an existing presence in Asia will need to stop peddling high calorie snacks and step up as GLP-1 companions
Weight loss and treatment patterns in a real-world population of adults receiving liraglutide 3.0 mg for weight management in routine clinical practice in Switzerland (ADDRESS study)
Tirzepatide is a dual GIP/GLP-1 receptor agonist, while Retatrutide (LY3437943) adds a third target the glucagon receptor making it a triple agonist studied for broader metabolic effects
Bottom line Clinical trials suggest retatrutide could be a promising new option for weight loss, but its not yet available
US$ 23.87
US$ 20.80
US$ 24.26
US$ 21.02
US$ 22.47
US$ 21.75
